发明授权
- 专利标题： Substituted piperazinyl amides and methods of use
- 专利标题（中）： 取代的哌嗪基酰胺和使用方法
-
申请号： US10202823申请日： 2002-07-24
-
公开(公告)号： US07115607B2公开(公告)日： 2006-10-03
- 发明人: Christopher H. Fotsch , Premilla Arasasingham , Yunxin Bo , Ning Chen , Martin H. Goldberg , Nianhe Han , Feng-Yin Hsieh , Michael G. Kelly , Qingyian Liu , Mark H. Norman , Duncan M. Smith , Markian Stec , Nuria Tamayo , Ning Xi , Shimin Xu
- 申请人： Christopher H. Fotsch , Premilla Arasasingham , Yunxin Bo , Ning Chen , Martin H. Goldberg , Nianhe Han , Feng-Yin Hsieh , Michael G. Kelly , Qingyian Liu , Mark H. Norman , Duncan M. Smith , Markian Stec , Nuria Tamayo , Ning Xi , Shimin Xu
- 申请人地址： US CA Thousand Oaks
- 专利权人： Amgen Inc.
- 当前专利权人： Amgen Inc.
- 当前专利权人地址： US CA Thousand Oaks
- 代理商 Joseph W. Bulock
- 主分类号： A61K31/496
- IPC分类号： A61K31/496 ; C07D401/12 ; C07D403/12
摘要：
Selected substituted piperazine compounds of Formula I are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
公开/授权文献
- US20030220324A1 Substituted piperazines and methods of use 公开/授权日：2003-11-27
信息查询
IPC分类:
